Bronchoalveolar Lavage Fluid Cellular Analysis and Radiologic Patterns in Patients with Fibrotic Interstitial Lung Disease.

Interstitial lung disease bronchoalveolar lavage bronchoscopy guidelines radiologic patterns

Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
21 Aug 2024
Historique:
received: 08 02 2024
revised: 27 06 2024
accepted: 08 07 2024
medline: 24 8 2024
pubmed: 24 8 2024
entrez: 23 8 2024
Statut: aheadofprint

Résumé

Bronchoalveolar lavage (BAL) cellular analysis is often recommended during the initial diagnostic evaluation of fibrotic ILD. Despite recommendation for its use, between-center heterogeneity exists and supportive data concerning the clinical utility and correlation of BAL findings with radiologic features or patterns remains sparse. In patients with fibrotic ILD, are BAL findings associated with radiologic features, patterns, and clinical diagnoses? Patients with fibrotic ILD who underwent BAL for diagnostic evaluation and enrolled in the prospective Canadian Registry for Pulmonary Fibrosis were re-reviewed in a standardized multidisciplinary discussion (MDD). BAL was categorized according to guideline-recommended thresholds, and also using thresholds of lymphocytosis>20% and neutrophils>4.5%. High-resolution computed tomography (HRCT) scans were scored (blinded to clinical data) for specific features and percentage lung involvement. Radiologists classified HRCTs according to guideline-defined patterns for idiopathic pulmonary fibrosis (IPF) and fibrotic hypersensitivity pneumonitis (fHP), then MDD diagnoses were assigned, considering all available data. Bronchoscopy with cellular analysis was performed in 209/1593 (13%) patients. Lymphocyte% was weakly negatively correlated with total fibrosis% (r=-0.16, p=0.023) but not statistically significantly correlated with ground glass opacity% (r=0.01, p=0.94). A mixed BAL pattern was the most frequent in all radiologic patterns (range 45% to 69%), with a minority classifiable according to BAL guidelines. BAL lymphocytosis appeared with similar frequency across HRCT patterns of fHP (21%) and UIP (18%). Only 5% of patients with MDD-based fHP had a guideline defined isolated lymphocytosis >15%. BAL cellular analyses did not significantly correlate with radiologic features, guideline patterns, or MDD-based diagnoses. Ground glass opacities are often interpreted to represent pulmonary inflammation, but were not associated with BAL lymphocytosis in this cohort.

Sections du résumé

BACKGROUND BACKGROUND
Bronchoalveolar lavage (BAL) cellular analysis is often recommended during the initial diagnostic evaluation of fibrotic ILD. Despite recommendation for its use, between-center heterogeneity exists and supportive data concerning the clinical utility and correlation of BAL findings with radiologic features or patterns remains sparse.
RESEARCH QUESTION OBJECTIVE
In patients with fibrotic ILD, are BAL findings associated with radiologic features, patterns, and clinical diagnoses?
METHODS METHODS
Patients with fibrotic ILD who underwent BAL for diagnostic evaluation and enrolled in the prospective Canadian Registry for Pulmonary Fibrosis were re-reviewed in a standardized multidisciplinary discussion (MDD). BAL was categorized according to guideline-recommended thresholds, and also using thresholds of lymphocytosis>20% and neutrophils>4.5%. High-resolution computed tomography (HRCT) scans were scored (blinded to clinical data) for specific features and percentage lung involvement. Radiologists classified HRCTs according to guideline-defined patterns for idiopathic pulmonary fibrosis (IPF) and fibrotic hypersensitivity pneumonitis (fHP), then MDD diagnoses were assigned, considering all available data.
RESULTS RESULTS
Bronchoscopy with cellular analysis was performed in 209/1593 (13%) patients. Lymphocyte% was weakly negatively correlated with total fibrosis% (r=-0.16, p=0.023) but not statistically significantly correlated with ground glass opacity% (r=0.01, p=0.94). A mixed BAL pattern was the most frequent in all radiologic patterns (range 45% to 69%), with a minority classifiable according to BAL guidelines. BAL lymphocytosis appeared with similar frequency across HRCT patterns of fHP (21%) and UIP (18%). Only 5% of patients with MDD-based fHP had a guideline defined isolated lymphocytosis >15%.
INTERPRETATION CONCLUSIONS
BAL cellular analyses did not significantly correlate with radiologic features, guideline patterns, or MDD-based diagnoses. Ground glass opacities are often interpreted to represent pulmonary inflammation, but were not associated with BAL lymphocytosis in this cohort.

Identifiants

pubmed: 39179174
pii: S0012-3692(24)04930-4
doi: 10.1016/j.chest.2024.07.166
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Aamanda Grant-Orser (A)

Department of Medicine, University of Calgary, Calgary, AB, Canada. Electronic address: Amanda.grant-orser@mail.mcgill.ca.

Michael Asmussen (M)

Department of Biology, Mount Royal University, Calgary, AB, Canada.

Daniel-Costin Marinescu (DC)

Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.

Cameron J Hague (CJ)

Department of Radiology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.

Nestor L Muller (NL)

Department of Radiology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.

Darra T Murphy (DT)

Department of Radiology, St James' Hospital, Dublin 8, Ireland.

Andrew Churg (A)

Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.

Joanne L Wright (JL)

Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.

Amna Al-Arnawoot (A)

Department of Radiology, McMaster University, St. Joseph's Healthcare Hamilton, ON, Canada.

Ana-Maria Bilawich (AM)

Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Patrick Bourgouin (P)

Department of Radiology, Radiation Oncology and Nuclear Medicine, University of Montreal, QC, Canada.

Gerald Cox (G)

Department of Medicine, McMaster University, Hamilton, ON, Canada.

Celine Durand (C)

Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.

Tracy Elliot (T)

Department of Radiology, University of Calgary, AB, Canada.

Jennifer Ellis (J)

Department of Radiology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.

Jolene H Fisher (JH)

Department of Medicine, University of Toronto, Toronto, ON, Canada.

Derek Fladeland (D)

Department of Medical Imaging, University of Saskatchewan, Saskatoon, SK, Canada.

Gillian C Goobie (GC)

Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

Zachary Guenther (Z)

Department of Radiology, University of Calgary, AB, Canada.

Ehsan Haider (E)

Department of Radiology, McMaster University, St. Joseph's Healthcare Hamilton, ON, Canada.

Nathan Hambly (N)

Department of Medicine, McMaster University, Hamilton, ON, Canada.

James Huynh (J)

Department of Radiology, University of Calgary, AB, Canada.

Geoffrey Karjala (G)

Department of Medical Imaging, University of Saskatchewan, Saskatoon, SK, Canada.

Nasreen Khalil (N)

Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Martin Kolb (M)

Department of Medicine, McMaster University, Hamilton, ON, Canada.

Jonathon Leipsic (J)

Department of Radiology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.

Stacey Lok (S)

Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.

Sarah MacIsaac (S)

Department of Medicine, McMaster University, Hamilton, ON, Canada.

Micheal McInnis (M)

Department of Medical Imaging, University of Toronto, Toronto, ON, Canada; University Medical Imaging Toronto, Toronto General Hospital, Toronto, ON, Canada.

Helene Manganas (H)

Department of Medicine, Université de Montréal, Montreal, QC, Canada.

Veronica Marcoux (V)

Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.

John Mayo (J)

Department of Radiology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.

Julie Morisset (J)

Department of Medicine, Université de Montréal, Montreal, QC, Canada.

Ciaran Scallan (C)

Department of Medicine, McMaster University, Hamilton, ON, Canada.

Tony Sedlic (T)

Department of Radiology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.

Shane Shapera (S)

Department of Medicine, University of Toronto, Toronto, ON, Canada.

Kelly Sun (K)

Department of Medicine, University of Toronto, Toronto, ON, Canada.

Victoria Tan (V)

Department of Medicine, McMaster University, Hamilton, ON, Canada.

Alyson W Wong (AW)

Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.

Boyang Zheng (B)

Division of Rheumatology, McGill University, Montreal, QC, Canada.

Christopher J Ryerson (CJ)

Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.

Kerri A Johannson (KA)

Department of Medicine, University of Calgary, Calgary, AB, Canada; Snyder Institute for Chronic Disease, University of Calgary, Calgary, AB ,Canada.

Classifications MeSH